his educational activity is designed for medical oncologists, radiation oncologists, surgical oncologists, pathologists, and other healthcare providers involved or interested in the diagnosis, treatment, and management of patients with breast cancer.
Objectives - Discuss the most clinically relevant and ground-breaking data presented at the 32nd Annual San Antonio Breast Cancer Symposium and integrate this emerging data into clinical practice
- Describe novel ways to personalize breast cancer therapy by incorporating new advances in gene profiling and prognostic markers
- Discuss the relevance of extranuclear receptor signaling to patient stratification for chemotherapeutic and endocrine therapy response and resistance
- Determine how the microenvironment and host-related factors can contribute to the disease progression of breast cancer, and ways to exploit this knowledge
- Evaluate promising novel targeted and epigenetic therapeutic strategies for the treatment of breast cancer, focusing on the benefits and limitations of these treatment regimens
- Debate the controversies in neoadjuvant and adjuvant therapy and analyze the efficacy of these agents in specific clinical scenarios
- Analyze emerging data on the use of bisphosphonates from trials assessing outcomes on bone health in breast cancer patients
